NCT05864612Completed
Tools for Anxiety and Depression Screening in Epilepsy
Developing Interoperable Tools for Anxiety and Depression Screening in Epilepsy
Source: ClinicalTrials.gov · Last updated 30 Oct 2025
Brief summary (registry, in English)
A randomized trial to compare patient-completion success of REDCap and Electronic Health Record (EHR)-based anxiety \& depression instrument delivery methods. Study hypothesis is that the screening completion proportion will vary across the 4 modalities tested.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 880 (actual)
- First submitted
- 9 May 2023
- Start date
- 20 Sept 2023
- Primary completion date
- 3 Sept 2024
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Epilepsy
- NCT number
- NCT05864612
What you commit to
- Study type: Interventional
- Participants enrolled: 880
- From 20 Sept 2023 to the primary completion date, 3 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No exclusions
Who the study is looking for
- Visit scheduled 7 days in advance at an adult-focused epilepsy clinic at the study site
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Atrium Health Wake Forest Baptist Coordinator of this site? Confirm its status | Winston-Salem | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.